prognostic biomarker

You have access
Dual Role of PSMB9 Linking Immune Activation and Tumor Adaptation in Hepatocellular Carcinoma With Therapeutic and Prognostic Implications
YITING LIU, JIAOJIAO CAO, HAIYANG YU, QICHEN SUN, TIANYI ZHU, YU ZHOU, XIAOYI DING, JIAN WANG, XIAOXIA GUO and ZHIYUAN WU

Anticancer Research March 2026, 46 (3) 1389-1410; DOI: https://doi.org/10.21873/anticanres.18036
You have access
Clinical Significance of LRG1 Protein Expression in Locally Advanced Gastric Cancer After Curative Resection
HAYATO WATANABE, TOMOKO JITSUKATA, YUKIHIKO HIROSHIMA, ITARU HASHIMOTO, NORIHIRO AKIMOTO, YUTA NAKAYAMA, SHINSUKE NAGASAWA, KYOHEI KANEMATSU, TAKANOBU YAMADA, TAKASHI OGATA, YOHEI MIYAGI, AYA SAITO and TAKASHI OSHIMA

Anticancer Research March 2026, 46 (3) 1619-1627; DOI: https://doi.org/10.21873/anticanres.18057
You have access
Oncogenic Role and Clinical Significance of NPM1 in Colorectal Cancer via the AKT/mTOR Signaling Pathway
HONG-BEUM KIM, HEE-JEONG LEE and SANG-GON PARK

Anticancer Research February 2026, 46 (2) 727-736; DOI: https://doi.org/10.21873/anticanres.17982
You have access
Pan-Cancer Landscape of CDK1 Uncovers Its Potential Prognostic Significance and Therapeutic Targeting in Adrenocortical Carcinoma
MOHD REHAN, FIROZ AHMED, MOHD SUHAIL and SHAZI SHAKIL

Anticancer Research February 2026, 46 (2) 771-785; DOI: https://doi.org/10.21873/anticanres.17986
You have access
POM121 Drives Gastric Cancer Progression via the mTOR/p70S6K Signaling Axis
HONG-BEUM KIM, SEONG-HUN KIM, HYE-HWA LEE, HEE-JEONG LEE and SANG-GON PARK

Anticancer Research February 2026, 46 (2) 787-795; DOI: https://doi.org/10.21873/anticanres.17987
You have access
High Claudin 18.2 Expression Predicts Favorable Outcomes in Pancreatic Ductal Adenocarcinoma After Curative Resection
HYEBIN CHA, EDEN DEMERE AMARE, YUN KYUNG JUNG, YOUNG HA OH, WOON YONG JUNG, SEUNGYUN JEE, SEONGSIK BANG, HWANGKYU SON, KIHYUK SONG, HOSUB PARK, JAEKYUNG MYUNG, SEUNGSAM PAIK, YESEUL KIM and HYUNSUNG KIM

Anticancer Research October 2025, 45 (10) 4565-4573; DOI: https://doi.org/10.21873/anticanres.17802
You have access
Discovery of a Copy-neutral Loss of Heterozygosity Pattern in Perihilar Cholangiocarcinoma With Potential Prognostic Value
SUTHEEMON TECHA-AY, SASITHORN WATCHARADETWITTAYA, RAKSAWAN DEENONPOE, KITTI INTUYOD, ANCHALEE TECHASEN, PORAMATE KLANRIT, WATCHARIN LOILOME, PRAKASIT SA-NGIAMWIBOOL and MALINEE THANEE

Anticancer Research September 2025, 45 (9) 3737-3748; DOI: https://doi.org/10.21873/anticanres.17734
You have access
Clinical Significance of PD-L1, LAG3, and VISTA in Patients With Poorly Cohesive Cell Gastric Cancer
YUN JI LEE, JIN HO BAEK, JONG GWANG KIM, KI BUM PARK, JI YEON PARK, OH KYOUNG KWON, AN NA SEO, MOON SIK KIM and BYUNG WOOG KANG

Anticancer Research September 2025, 45 (9) 3939-3951; DOI: https://doi.org/10.21873/anticanres.17752
Open Access
Circulating Tumor DNA Methylation Is a Biomarker of Poor Recurrence-free Survival in Locally-Advanced Rectal Cancer
KIICHI SUGIMOTO, TAKAHIRO IRIE, HIROTAKA MOMOSE, SAKI KOCHI, MIYUKI TOAKE, YUKI TSUCHIYA, RYOICHI TSUKAMOTO, KUMPEI HONJO, SHUN ISHIYAMA, MAKOTO TAKAHASHI, ROBERT M. HOFFMAN and KAZUHIRO SAKAMOTO

Anticancer Research April 2025, 45 (4) 1559-1573; DOI: https://doi.org/10.21873/anticanres.17537
Open Access
SLC15A2 Serves as a Novel Prognostic Biomarker and Target for Prostate Cancer
WENJUN YIN, PINGKAIQI HE, ZHIHAO ZOU, JUNDONG LIN, ZHENGUO LIANG, ZHENJIE WU, JIANHENG YE, JIANMING LU and WEIDE ZHONG

Anticancer Research January 2025, 45 (1) 153-172; DOI: https://doi.org/10.21873/anticanres.17402

Main menu

User menu

Search

prognostic biomarker

Pages